CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Curis Gains As Blood Cancer Drug Progresses, December Readout in Focus

Data ReadoutPositive
AI Analysis

Summary

Curis is progressing a blood cancer drug with a data readout expected in December 2026. The company gained on the positive development outlook.

Clinical Trial Data

Importance:6/10
Sentiment:
0.50
blood cancerdrug developmentclinical trial readout
Related Companies

Read the original article

Published by yahoo_finance on July 27, 2026 4:30 PM

Read Original